Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 vistas
• 07/30/23
0
0
Empotrar
administrator
Suscriptores
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios